| Literature DB >> 34779914 |
Jia Lun Lim1,2, Katja Lohmann3, Ai Huey Tan2,4, Yi Wen Tay1,2, Khairul Azmi Ibrahim5, Zariah Abdul Aziz5, Ahmad Shahir Mawardi6, Santhi Datuk Puvanarajah6, Thien Thien Lim7,8, Irene Looi9, Joshua Chin Ern Ooi10, Yuen Kang Chia10, Kalai Arasu Muthusamy11, Peter Bauer12, Arndt Rolfs12, Christine Klein3, Azlina Ahmad-Annuar13, Shen-Yang Lim14,15.
Abstract
GBA variants are associated with increased risk and earlier onset of Parkinson's disease (PD), and more rapid disease progression especially with "severe" variants typified by p.L483P. GBA mutation screening studies from South-East Asia, with > 650 million inhabitants of diverse ancestries, are very limited. We investigated the spectrum of GBA variants, and associated clinico-demographic features, in a multi-ethnic PD cohort in Malaysia. Patients (n = 496) were recruited from seven centres, primarily of Chinese (45%), Malay (37%), and Indian (13%) ethnicities. All GBA coding exons were screened using a next-generation sequencing-based PD gene panel and verified with Sanger sequencing. We identified 14 heterozygous GBA alleles consisting of altogether 17 missense variants (8 classified as pathogenic or likely pathogenic for PD) in 25 (5.0%) patients, with a substantially higher yield among early (< 50 years) vs. late-onset patients across all three ethnicities (9.1-13.2% vs. 1.0-3.2%). The most common variant was p.L483P (including RecNciI, n = 11, 2.2%), detected in all three ethnicities. Three novel variants/recombinant alleles of uncertain significance were found; p.P71L, p.L411P, and p.L15S(;)S16G(;)I20V. The common European risk variants, p.E365K, p.T408M, and p.N409S, were not detected. A severe disease course was noted in the majority of GBA-variant carriers, across a range of detected variants. We report a potentially novel observation of spine posture abnormalities in GBA-variant carriers. This represents the largest study on GBA variation from South-East Asia, and highlights that these populations, especially those with EOPD, would be relevant for studies including clinical trials targeting GBA pathways.Entities:
Keywords: Camptocormia; Early-onset PD; GBA; Genetics; Parkinson’s disease
Mesh:
Substances:
Year: 2021 PMID: 34779914 DOI: 10.1007/s00702-021-02421-0
Source DB: PubMed Journal: J Neural Transm (Vienna) ISSN: 0300-9564 Impact factor: 3.575